Phenotypic and Genetic Factors in Autism Spectrum Disorders
Overview
The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: January 2027
Detailed Description
Participation in this research study involves two research visits, at least one of which is at Children's Hospital Boston. The first visit lasts about 4-6 hours. On this visit, the child will work with a research assistant on a few different cognitive assessments while one or both parents answer interview questionnaires about the child's development, along with other family history information. The second visit at the hospital lasts about 2 and a half hours and involves medical history and family history questionnaires, as well as height, weight, and head circumference measurements and a blood draw from each family member. In addition, digital photographs will be taken of each family member and a 3-D picture of the child's face will be taken. Shortly after the visits, participants will receive a research report of our observations. These results include cognitive, behavioral, developmental, and social findings. The total time commitment for the study is 6 to 8 hours.
Clinical Trial Outcome Measures
Primary Measures
- genotype-phenotype correlation
- Time Frame: enrollment and sample analysis
Participating in This Clinical Trial
Inclusion Criteria
- Diagnosis of autism spectrum disorder or suspected diagnosis based on clinical genetic test results (e.g., variant diagnosed via chromosomal microarray) – Age ≥ 18 months Exclusion Criteria:
- Presence of a metabolic disorder – Acquired developmental disability (e.g., birth asphyxia, trauma-related injury, meningitis, etc.) or cerebral palsy
Gender Eligibility: All
Minimum Age: 18 Months
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Boston Children’s Hospital
- Collaborator
- National Institute of Mental Health (NIMH)
- Provider of Information About this Clinical Study
- Principal Investigator: Christopher Walsh, Professor of Genetics and Pediatrics, Harvard Medical School – Boston Children’s Hospital
- Overall Official(s)
- Christopher Walsh, MD, PhD, Principal Investigator, Boston Children’s Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.